NOAEL Studies
Cosmetic Ingredient
Basic Orange 31 NOAEL Studies
INCI: BASIC ORANGE 31
CAS: 97404-02-9
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 229 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCS; RCC Project 699647. (1999). Subchronic 13-week oral toxicity (feeding) study in therat |
| COSMOS DB | NOAEL | 66 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCS; RCC Project 699647. (1999). Subchronic 13-week oral toxicity (feeding) study in therat |
SCCNFP Opinion 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =1 | % | - | dermal | - | repeated dose toxicity | Ref : 3 2, p.7 |
| SCCNFP Opinion | NOAEL | =15 | mg/kg | rat | dermal | 14 days | repeated dose toxicity | Ref : 4 2, p.7 |
| SCCNFP Opinion | NOAEL | =18 | mg/kg | rat | dermal | Sub-chronic | repeated dose toxicity | Ref : 5 2, p.9 |
| SCCNFP Opinion | NOAEL | =18 | mg/kg bw/day | - | oral | sub-chronic | repeated dose toxicity | p.21 |
| SCCNFP Opinion | NOAEL | =53 | mg/kg bw | rat | dermal | 14 days | repeated dose toxicity | Ref : 4 2, p.7 |
| SCCNFP Opinion | NOAEL | =53 | mg/kg bw/day | - | oral | sub-chronic | repeated dose toxicity | p.21 |
| SCCNFP Opinion | NOAEL | =60 | mg/kg | rat | dermal | Sub-chronic | repeated dose toxicity | Ref : 5 2, p.9 |
| SCCNFP Opinion | NOAEL | =60 | mg/kg bw/day | - | oral | sub-chronic | repeated dose toxicity | p.21 |
SCCS Opinion 9 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =94.1 | % | rabbit | dermal | - | irritation | p.11 |
| SCCS Opinion | NOAEL | =15 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.18 |
| SCCS Opinion | NOAEL | =53 | mg/kg bw | rat | oral | Sub-chronic | repeated dose toxicity | p.18 |
| SCCS Opinion | NOAEL | =18 | mg/kg bw/day | rat | - | Chronic | genotoxicity | p.19 |
| SCCS Opinion | NOAEL | =60 | mg/kg bw/day | rat | - | Chronic | genotoxicity | p.19 |
| SCCS Opinion | NOAEL | =0.0013 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.28 |
| SCCS Opinion | NOAEL | =60 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.28 |
| SCCS Opinion | NOAEL | =0.0011 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =53 | mg/kg bw/day | rat | oral | 28-day | reproductive toxicity | p.29 |
Regulatory source 20 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | developmental toxicity | 60 | mg/kg | human | - | - | developmental toxicity | p.13 |
| Regulatory source | repeated dose toxicity | 1 | % | - | dermal | - | repeated dose toxicity | p.7 |
| Regulatory source | repeated dose toxicity | 15 | mg/kg | rat | dermal | 14 days | repeated dose toxicity | p.7 |
| Regulatory source | repeated dose toxicity | 18 | mg/kg | rat | dermal | Sub-chronic | repeated dose toxicity | p.9 |
| Regulatory source | repeated dose toxicity | 18 | mg/kg bw/day | - | oral | sub-chronic | repeated dose toxicity | p.21 |
| Regulatory source | repeated dose toxicity | 53 | mg/kg bw | rat | dermal | 14 days | repeated dose toxicity | p.7 |
| Regulatory source | repeated dose toxicity | 53 | mg/kg bw/day | - | oral | sub-chronic | repeated dose toxicity | p.21 |
| Regulatory source | repeated dose toxicity | 60 | mg/kg | rat | dermal | Sub-chronic | repeated dose toxicity | p.9 |
| Regulatory source | repeated dose toxicity | 60 | mg/kg bw/day | - | oral | sub-chronic | repeated dose toxicity | p.21 |
| Regulatory source | dermal absorption | =0.0013 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.28 |
| Regulatory source | dermal absorption | =60 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.28 |
| Regulatory source | dermal absorption | =0.0011 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.29 |
| Regulatory source | developmental toxicity | 60 | mg/kg bw/day | mouse | oral | - | developmental toxicity | p.25 |
| Regulatory source | genotoxicity | 18 | mg/kg bw/day | rat | - | Chronic | genotoxicity | p.19 |
| Regulatory source | genotoxicity | 60 | mg/kg bw/day | rat | - | Chronic | genotoxicity | p.19 |
| Regulatory source | irritation | 94.1 | % | rabbit | dermal | - | irritation | p.11 |
| Regulatory source | repeated dose toxicity | 15 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.18 |
| Regulatory source | repeated dose toxicity | 53 | mg/kg bw | rat | oral | Sub-chronic | repeated dose toxicity | p.18 |
| Regulatory source | reproductive toxicity | 53 | mg/kg bw/day | rat | oral | 28-day | reproductive toxicity | p.29 |
| Regulatory source | reproductive toxicity | 60 | mg/kg bw/day | rat | oral | 28-day | reproductive toxicity | p.29 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | O1JIQ710E2 | UNII | - | - | - | chemical | - |